In today's world, context is clarity, our podcast series highlights advocacy, education, industry, and scientific advancements in the space bringing congenital cytomegalovirus (CMV) to the forefront of the conversation.


Tami Hoffman and LOHL

Join the National CMV Team as they speak with CMV parent, Tami Hoffman, LMSW, during Late Onset Hearing Loss (LOHL) Awareness Week.

Alyson Ward and the CMV Public Health & Policy Conference

Join the National CMV team as they speak with CMV advocate and Director of Quality Improvement for the National Center for Hearing Assessment and Management (NCHAM), Alyson Ward. 

Meet Kenya Simmons

The National CMV Team had the privilege of speaking with Kenya Simmons, a dedicated intern and student, working closely with the Foundation.

Dr. Megan Pesch & Navigating Care

Tune in to hear from our very own Dr. Megan Pesch as she discusses navigating care after a developmental disability diagnosis.

Meet Samantha Banerjee: PUSH for Empowered Pregnancy

Samantha catchs up with co-hosts Khaliah and Dr. Jennifer Jenks to share about PUSH's agenda and 2022 activities.

Meet Lisa Eickel: CMV Community Alliance Chair

Lisa shares her experiences as a Speech-Language Pathologist and active CMV advocate.

Meet Richard Hughes IV from Moderna

Moderna is now a household name. What is mRNA and how will CMV awareness and policy shape the future for a CMV vaccine?

Meet Ilene Miller from Rare Epilepsy Network (REN)

CMV outcomes may include one or some potential neurological disorders. Learn more about one of our partners, Rare Epilepsy Network (REN) from its Director, Ilene Penn Miller. 

Meet Tammy Boyd from the Black Women’s Health Imperative

Learn more about the Rare Disease Diversity Coalition, fueled by the Black Women's Health Imperative, and their work to alleviate the disproportionate burden of rare diseases on communities of color. 

Meet Sharon Wood with CMV Action UK

CMV is a global public health issue. Learn more about one of our partners, Sharon Wood from CMV Action UK, and how she continues to push forward with their important work in the time of COVID-19.